TABLE 4.
Tumor-neutralizing activity of spleen cells obtained from TB rats treated with CAM
| Treatment of spleen cell donora | Tumor wt (g)b | |
|---|---|---|
| Day 8 | Day 12 | |
| TB (day 15) | ||
| CAM (days 1–14) | 0.85 ± 0.08c | 1.97 ± 0.17d | 
| None | 1.05 ± 0.17 | 2.82 ± 0.49 | 
| Non-TB | ||
| CAM (days 1–14) | 1.11 ± 0.16 | 2.33 ± 0.21 | 
| None | 1.38 ± 0.16 | 3.09 ± 0.30 | 
| Tumor cell alone | 1.31 ± 0.08 | 2.93 ± 0.33 | 
13762NF cells (2 × 106) were administered s.c. on day 0. CAM was administered at 2 mg/kg p.o. on days 1 to 14, with removal of spleens on day 15.
A mixture of tumor cells (1 × 106) and spleen cells (80 × 106) was inoculated s.c. into syngeneic rats, and the tumors were then weighed on days 8 and 12 after the inoculation. Each group contained four to six rats.
P < 0.01 versus the tumor cell-alone group.
P < 0.05 versus the tumor cell-alone group.